Clinical application of excimer laser ablation in lower extremity arterial ischemic diseases
10.3760/cma.j.issn115396-20230505-00115
- VernacularTitle:准分子激光消蚀术在下肢动脉缺血性疾病中的临床应用
- Author:
Yangyang LI
1
;
Sicheng YAO
;
Jiareke TANG
;
Jianping YANG
;
Bing ZHU
;
Sheng GUAN
;
Xiaohu GE
;
Hongbo CI
Author Information
1. 新疆维吾尔自治区人民医院血管外科，乌鲁木齐 830001
- Keywords:
Laser;
Plaque ablation;
Arteriosclerosis;
Lower limbs;
Vascular disease
- From:
International Journal of Surgery
2023;50(7):468-473
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the therapeutic effect of excimer laser ablation (ELA) in the treatment of lower extremity arterial ischemic diseases.Methods:The clinical data of 44 patients with lower extremity ischemic diseases treated with ELA in the People′s Hospital of Xinjiang Uygur Autonomous Region from December 2020 to April 2021 were analyzed retrospectively. Among the 44 patients, there were 29 patients in lower extremity arteriosclerosis obliterans (ASO), including 3 patients with femoral artery stent occlusion. 8 patients of diabetes foot (DF) and 7 patients of thromboangiitis obliterans (TAO). Observation indicators include target vascular patency rate, amputation rate, vascular reintervention rate and mortality rate. The measurement data were expressed as mean ± standard deviation ( ± s), one-way analysis of variance was used for inter-group comparison, and paired sample t-test was used for intra-group comparison. The Chi-square test was used for comparison between count data. Results:The success rate of operation was 100% in 44 patients. The rate of major amputation in ASO group was 10.3%, while the other two groups had a major amputation rate of 0. The minor amputation rates of the three groups were 6.9%, 25.0% and 28.6%, respectively. The vascular reintervention rate was 10.3% in ASO group, 12.5% in DF group and 0 in TAO group. The 1-year mortality rate in the ASO group was 10.3%, while the other two groups had a mortality rate of 0. The 2-year mortality rate of the three group were 31.0%, 12.5% and 0, respectively.Conclusion:For the treatment of lower extremity arterial ischemic diseases, ELA is safe and effective, but the curative effect need to further clarify by large sample and long-term clinical follow-up observation.
